Amarin Pfizer
Amarin PfizerAmarin, in many ways, would be an ideal pick-up for Pfizer, especially with the big pharma's ongoing metamorphosis into a growth-oriented company. This has been particularly true for colchicine, an inexpensive anti-inflammatory therapy that reduced cardiovascular event rates in two major randomized trials with a benefit at least as large as. DUBLIN, Ireland and BRIDGEWATER, N. First, the company lost a patent trial against two generic drug makers seeking to sell their own versions of Vascepa.
CRP More Predictive of Future Events Than LDL in Statin.
Pfizer's pipeline is as strong as it's been in a long time. , May 12, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted new data describing the benefits of VASCEPA ® /VAZKEPA ® (icosapent. Pfizer (PFE) recently acquired an ontology company and could acquire Amarin (AMRN) next. Pfizer has a cardiovascular and metabolic diseases unit that focuses, in part, on heart failure and related problems. At least that is how one analyst currently sees the situation for Amarin ( AMRN ), the maker of high triglycerides treatment, Vascepa.
Pfizer Salaries in Algiers, Algeria.
Earlier this month, Pfizer entered into a promotional agreement to push Amarin's Vascepa product in Canada and could be a sign that an acquisition is under way. Vascepa is the first-and-only prescription treatment designed to reduce the risk of major adverse cardiac. The goal of this activity is to discuss the identification of patients with dyslipidemia at high risk of cardiovascular (CV) events, as well as strategies to reduce that risk. lettruthringout: Amarin/Pfizer can potentially promote Vascepa for COVID-19 Assuming Prepare-It 1 has positive results, can that information be used by Pfizer' Support: 888-992-3836 Home NewsWire Subscriptions. 3% in the patients treated with tocilizumab and 63. Upon completion of this activity, participants will: Have increased knowledge regarding the.
Amarin: What The Street Hasn't Factored In And Why Amarin Is ">Amarin: What The Street Hasn't Factored In And Why Amarin Is.
Background/Synopsis PCSK9 inhibitors (alirocumab and evolocumab) became commercially available in July and August of 2015, respectively. Mason reports research grants, consulting fees and honoraria from Amarin, Pfizer and HLS Therapeutics. 13, 2019 4:30 AM ET Amarin Corporation plc (AMRN) PFE 18 Comments.
8 Largest Coal Mines in Indonesia.
They have been shown to be effective in improving cardiovascular outcomes in patients not adequately responding to statin and other cholesterol lowering therapies. lettruthringout: Amarin/Pfizer can potentially promote Vascepa for COVID-19 Assuming Prepare-It 1 has positive results, can that information be used by Pfizer' Support: 888-992-3836 Home NewsWire Subscriptions. Technical analysis trends AMARIN CORPORATION PLC Technical analysis Income Statement Evolution More Financials Consensus Consensus EPS Revisions More Estimates Revisions Managers and Directors More about the company More Results. Amarin Corp - ADR (AMRN) Stock Price Today, News, Quotes, FAQs and Fundamentals Home Symbol AMRN AMRN Amarin Corp - ADR 31,245 $1. The goals of this program are for clinicians to: Personalize the intensity and duration of dual antiplatelet therapy (DAPT) to optimize clinical outcomes after percutaneous coronary intervention (PCI) Incorporate more potent and extended DAPT into the treatment of patients with type 2 diabetes. It has more than 90,000 hectares of coal mines that manage by some companies. Amarin makes Vascepa, a treatment to help lower triglycerides in adults. With the largest coal mines, Sangatta becomes the busiest city in East Kalimantan.
Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price.
Pfizer for ">HLS Therapeutics inks promotional agreement with Pfizer for.
Vascepa, an innovative therapeutic prescription medicine for treating cardiovascular disease, is used in conjunction with medicines called statins, such as Pfizer's Lipitor, which help fight high. At least that is how one analyst currently sees the situation for Amarin ( AMRN ), the maker of high triglycerides treatment, Vascepa. for the promotion of Vascepa in Canada. Pfizer will deploy a team to support. Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. The company's stock has been rising for the past two. The average Pfizer hourly. Tardif reported research grants from Amarin, AstraZeneca, Ceapro, DalCor Pharmaceuticals, Esperion, Merck, Novartis, Pfizer, and RegenXBio; honoraria from AstraZeneca, DalCor Pharmaceuticals,. Amarin reiterates its belief that current cash and investments and other assets are adequate to support continued operations, including European launch. HLS Therapeutics, with Pfizer in Canada.
AMRN Amarin Corporation plc.
The Daily Biotech Pulse: Pfizer, BioNTech File Marketing ….
Speculations are rife about rising M&A activity in the. lettruthringout: Amarin/Pfizer can potentially promote Vascepa for COVID-19 Assuming Prepare-It 1 has positive results, can that information be used by Pfizer' Support: 888-992-3836 Home NewsWire Subscriptions. For their meta-analysis, the researchers analyzed data from PROMINENT, REDUCE-IT, and STRENGTH—all originally designed to test triglyceride-lowering—for a combined total of 31,245 patients with, or at high risk of, atherosclerotic disease who were already receiving statins. Amarin, in many ways, would be an ideal pick-up for Pfizer, especially with the big pharma's ongoing metamorphosis into a growth-oriented company. Analysts at Jefferies think the product could bring in $2bn at peak, so it will be interesting to see how much Pfizer might be prepared to pay for that potential.
Pfizer Shareholders Win With an Acquisition of Amarin?">Would Pfizer Shareholders Win With an Acquisition of Amarin?.
Amarin, currently valued at around $21 per share, could be the target of a big acquisition with an FDA decision on a heart-helping label expansion for Vascepa coming late next month and. 05/16/23 10:29 PM Pfizer certainly cleaned up. Business: Amarin engages in the development and commercialization of therapeutics for the treatment of cardiovascular. 1% reduction in the primary end point of LDL cholesterol at 12 weeks compared with a 2. The average Pfizer salary ranges from approximately $43,630 per year for a Warehouse Worker to $508,034 per year for a Vice President. BioSci Capital Partners's Blog. DUBLIN, Ireland and BRIDGEWATER, N. 6% in those treated with placebo, a significant 5. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Amarin is predicting revenues of $224m to $228m this year and says the REDUCE-IT data could push its top-line up more than 50% to $350m or so this year.
Amarin Highlights New Data Providing Potential Mechanistic.
Amarin is relentless in its pursuit of. Pfizer's pipeline is as strong as it's been in a long time. Amarin (AMRN) shares rally on rumors of its potential; acquisition by large pharmaceutical company, Pfizer. Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors • GlobeNewswire Inc. Sangatta becomes the region with the largest coal mines in Indonesia that is located in Kutai Timur regency, East Kalimantan. • 04/17/2023 11:00:00 AM Amarin Announces. Shares of Amarin Corporation plc AMRN rallied 22. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. S hares of Amarin Corporation plc AMRN rallied 22.
Pfizer Reviews in Algiers, Algeria.
Outlook and plans for international expansion in 2022 to include:. S hares of Amarin Corporation plc AMRN rallied 22.
Amarin (AMRN) Will Make Excellent Takeover Target, Says Analyst.
Amarin's recent "Reduce-It" clinical trial results for its Vascepa drug were better than those of Pfizer's Lipitor, a drug that reached peak sales of $13. VASCEPA is a prescription medicine used: along with certain medicines (statins) to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with heart (cardiovascular) disease, or diabetes and 2 or more additional risk factors for heart disease. Amarin definitely has a potential blockbuster on its hands with Vascepa. Amarin makes Vascepa, a treatment to help lower triglycerides in adults. At Pfizer, we are proud of our efforts to create a culture where we support our colleagues and create opportunities for growth. Eckel has no conflicts of interest to report. Based in Dublin Ireland, Amarin Corporation is focused on the innovation and commercialization of medicine to improve the outcomes of cardiovascular diseases. Amarin is fully capitalized after their last $200m equity raise last November.
Study finds residual inflammation after stati.
AMRN Stock Price - Amarin Corp. The phase 2, proof-of-concept study was prompted by the team's earlier work in non-STEMI patients, in which a single dose of the interleukin-6 (IL-6) receptor antagonist cut C-reactive protein. Probably the biggest argument against Pfizer buying Amarin is that the drugmaker really doesn't have to make a deal right now. This #BlackHistoryMonth, join us #LIVE. Amarin: Evaluating The Merits Of A Potential Pfizer Acquisition. Myocardial salvage index, which is defined as the proportion of the myocardium at risk salvaged by treatment following PCI, was 69. AMRN Stock Price - Amarin Corp. Amarin, currently valued at around $21 per share, could be the target of a big acquisition with an FDA decision on a heart-helping label expansion for Vascepa coming late next month and. Would Pfizer Shareholders Win With an Acquisition of Amarin? | Nasdaq Skip to main content Market Activity Market Activity-> Stocks Options Funds + ETFs Indexes Commodities Cryptocurrency. 10, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today provided a business update, including preliminary unaudited full-year 2021 revenue results. Dr Tardif reports grants from Amarin, AstraZeneca, Ceapro, DalCor Pharmaceuticals, Esperion, Ionis, Novartis, Pfizer and RegenXBio; honoraria from AstraZeneca, DalCor Pharmaceuticals, HLS Pharmaceuticals, Pendopharm and Pfizer; minor equity interest in DalCor Pharmaceuticals; and patents on pharmacogenomics‐guided CETP inhibition and use of. Pfizer has a cardiovascular and metabolic diseases unit that focuses, in part, on heart. George Budwell has no position in any of the.
Amarin Corporation plc (AMRN) Stock Price Today, Quote & News.
Amarin/Pfizer can potentially promote Vascepa for COVID-19 Assuming Prepare-It 1 has positive results, can that information be used by Pfizer's Canadian sales reps when they visit physicians?. Would Pfizer Shareholders Win With an Acquisition of Amarin? | Nasdaq Skip to main content Market Activity Market Activity-> Stocks Options Funds + ETFs Indexes Commodities Cryptocurrency. Earlier this month, Pfizer entered into a promotional agreement to push Amarin’s Vascepa product in Canada and could be a sign that an acquisition is under way. Presented earlier this week at the American College of Cardiology 2019 Scientific Session, the CLEAR Wisdom trial showed that bempedoic acid cut LDL cholesterol by 15. Amarin has partnered with Eddingpharm since 2015 with no China approval of Vascepa as yet for the mainlandPerhaps its time for Amarin to look elsewhere PFE: Pfizer collaborates with. 1% on Thursday, possibly on speculations that Pfizer ( PFE Quick Quote PFE - Free Report) may bid to acquire. Amarin Corporation plc (AMRN) Stock Forum & Discussion - Yahoo Finance Finance Home Watchlists My Portfolio Markets News Videos Yahoo Finance Plus Screeners Personal Finance Crypto Industries. 04 About Feed Fundamentals News Latest AMRN News View 3rd Party Ad. Probably the biggest argument against Pfizer buying Amarin is that the drugmaker really doesn't have to make a deal right now. Probably the biggest argument against Pfizer buying Amarin is that the drugmaker really doesn't have to make a deal right now. Vascepa is the first-and-only prescription treatment designed to reduce. Amarin's product development program. “Moving anti-inflammatory interventions from stable atherosclerosis into acute ischemia is of considerable clinical relevance, although mechanisms likely differ and relate more to ischemia/reperfusion injury and the consequences of plaque rupture than to atherosclerotic progression,” he writes. Background/Synopsis PCSK9 inhibitors (alirocumab and evolocumab) became commercially available in July and August of 2015, respectively. 13, 2019 4:30 AM ET Amarin Corporation plc (AMRN) PFE 18 Comments. For every giant drugmaker like Pfizer, Merck or Johnson & Johnson, whose products are in medicine cabinets around the world, there are countless startups and small biopharmaceutical firms chasing. Amarin is fully capitalized after their last $200m equity raise last November.
Would Pfizer Shareholders Win With an Acquisition of Amarin?">Would Pfizer Shareholders Win With an Acquisition of Amarin?.
Amarin Corp PLC (AMRN): Amarin has partnered with Eddingpharm.
The drug is also awaiting approval in China, where Amarin hopes to target the 50 million-plus cardiovascular disease patients with elevated risks.
Amarin Corp PLC (AMRN): Amarin/Pfizer can potentially promote ….
Amarin Corporation plc (AMRN) Stock Price Today, Quote & News | Seeking Alpha AMRN Amarin Corporation plc Stock Price & Overview $1.
HLS Enters Agreement With Pfizer For Promotion Of ….
Patients treated with the investigational oral agent had a 15. Disclosures Individual disclosures* • AC Goldberg: Grants/Research support: Amgen, Amarin, Pfizer, Regeneron, Sanofi, IONIS; Honoraria: National Lipid. Amarin makes Vascepa, a treatment to help lower triglycerides in adults. The goals of this program are for clinicians to: Personalize the intensity and duration of dual antiplatelet therapy (DAPT) to optimize clinical outcomes after percutaneous coronary intervention (PCI) Incorporate more potent and extended DAPT into the treatment of patients with type 2 diabetes.
Amarin Corp PLC (AMRN): Amarin/Pfizer can potentially promote Va.
Not an offer or recommendation by Stocktwits. Net cash is currently $249m and, as of Q4, they've already contacted 20,000 of the 50,000 doctors who write 50% of. Amarin: Evaluating The Merits Of A Potential Pfizer Acquisition. 16, 2021 6:55 AM ET Pfizer Inc.
Company behind heart drug could have folded after loss in.
January historically brings deals and rumors of deals in the biopharmaceutical industry.
Arthritis Drug May Curb Myocardial Damage in Acute STEMI">Arthritis Drug May Curb Myocardial Damage in Acute STEMI.
Arthritis drug may curb myocardial damage in acute STEMI.
Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors • GlobeNewswire Inc. Amarin, currently valued at around $21 per share, could be the target of a big acquisition with an FDA decision on a heart-helping label expansion for Vascepa coming late next month and.
What's Next for Amarin's Stock?.
TO) has entered into a promotional services agreement with Pfizer Inc. Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. AMRN Stock Price - Amarin Corp. 21 hours ago · Amarin Corp PLC (AMRN): Pfizer is raising $31 billion in debt to SMALL CAP PRO Realtime Streaming Prices and Level 2. Pfizer is said to be interested in Amarin, but the Danish group’s need for a growth injection is greater. At the heart of the company is. Amarin: Evaluating The Merits Of A Potential Pfizer Acquisition. Pfizer (PFE) recently acquired an ontology company and could acquire Amarin (AMRN) next.
Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer.
Amarin has partnered with Eddingpharm since 2015 with no China approval of Vascepa as yet for the mainlandPerhaps its time for Amarin to look elsewhere PFE: Pfizer collaborates with. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary solutions that create a healthier world. Amarin Corp PLC (AMRN) Message Board - Company Name: Amarin Corp PLC, Stock Symbol: AMRN, Industry: Biotechs - Total Posts: 409141 - Last Post: 05/16/2023 11:02:43 PM - company/specific stock board Pfizer is raising $31 billion in debt to. HLS in-licensed the exclusive rights to Vascepa for the Canadian market from Amarin.
Would Pfizer Shareholders Win With an Acquisition of ….
Pfizer Stock Down On Possible Bid For Amarin.
Yet the Street only has an average. Amarin Corp PLC (AMRN): Pfizer is raising $31 billion in debt to SMALL CAP PRO Realtime Streaming Prices and Level 2. Amarin is predicting revenues of $224m to $228m this year and says the REDUCE-IT data could push its top-line up more than 50% to $350m or so this year. Amarin definitely has a potential blockbuster on its hands with. Vascepa, an innovative therapeutic prescription medicine for treating cardiovascular disease, is used in conjunction with medicines called statins, such as Pfizer's Lipitor, which help fight high. At least that is how one analyst currently sees the situation for Amarin ( AMRN ), the maker of high triglycerides treatment, Vascepa.
Amarin Highlights New Data Providing Potential Mechanistic ">Amarin Highlights New Data Providing Potential Mechanistic.
Join the Conversation! Build your trading network; Follow your favorite assets. 1% at 12 weeks, as well as lowered total cholesterol, apolipoprotein B, non-HDL cholesterol, and C-reactive protein levels. Amarin is predicting revenues of $224m to $228m this year and says the REDUCE-IT data could push its top-line up more than 50% to $350m or so this year. The first few weeks in 2019 haven't disappointed, with a. "At Amarin, we’re focused on improving the lives of those with cardiovascular disease. supply, manufacturing, and distribution sites are focused on ensuring that all Pfizer products are made to the highest standards of quality, safety, and efficacy.
Modest LDL Cholesterol Reduction With Bempedoic Acid in ….
lettruthringout: Amarin/Pfizer can potentially promote Vascepa for COVID-19 Assuming Prepare-It 1 has positive results, can that information be used by Pfizer' Support: 888-992-3836 Home NewsWire Subscriptions. In August 2021, its Canadian partner HLS Therapeutics inked a promotional agreement with Pfizer for the promotion of VASCEPA/VAZKEPA to the country’s primary care physician market. Earlier this month, Pfizer entered into a promotional agreement to push Amarin’s Vascepa product in Canada and could be a.
Amarin Corp PLC (AMRN): CB, I know for a fact that Pfizer was ">Amarin Corp PLC (AMRN): CB, I know for a fact that Pfizer was.
Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease.
Amarin Corp PLC (AMRN): Amarin/Pfizer can potentially promote.
Efficacy and Safety of Bempedoic Acid Added to Maximally ….
HLS Enters Agreement With Pfizer For Promotion Of Vascepa In.
Ridker has received investigator-initiated research grant support from Kowa, Novartis, Amarin, Pfizer, and the National Heart, Lung, and Blood Institute; and has served as a consultant to Novartis, Janssen, Agepha, Flame, Civi Biopharma, Inflazome, Corvidia, Novo Nordisk, SOCAR, IQVIA, and AstraZeneca. “Moving anti-inflammatory interventions from stable atherosclerosis into acute ischemia is of considerable clinical relevance, although mechanisms likely differ and relate more to ischemia/reperfusion injury and the consequences of plaque rupture than to atherosclerotic progression,” he writes. However, there are several reasons why an acquisition of Amarin by Pfizer could pay off nicely.
Rumor: Will Pfizer (PFE) acquire Amarin (AMRN) next?.
Global Lung Cancer Franchise Lead at Pfizer Inc 1mo. TO) has entered into a promotional services agreement with Pfizer Inc. HLS in-licensed the exclusive rights to Vascepa for the Canadian market from Amarin. The biotech was assaulted last week on two fronts. Amarin's product development program. Shares of Amarin Corporation plc ( AMRN Quick Quote AMRN - Free Report) rallied 22. Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease.
Amarin Highlights New Data Providing Potential Mechanistic ….
START YOUR FREE TRIAL > NEW to INVESTORSHUB Home Boards US Listed.
Karim Mikhail, President and CEO of Amarin Corporation.
Amarin to Buy From Hold, Adjusts Price ">Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price.
Changing Between PCSK9 Inhibitor Medications.
1% on Thursday, possibly on speculations that Pfizer PFE may bid to acquire the company. , May 12, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted new data describing the benefits of VASCEPA ® /VAZKEPA ® (icosapent. Business: Amarin engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Based in Dublin Ireland, Amarin Corporation is focused on the innovation and commercialization of medicine to improve the outcomes of cardiovascular diseases. Stocks In Focus Amarin Accuses Hikma Of Infringing Vascepa Patents. Its product development program leverages its experience. 24%) 4:00 PM 05/12/23 NASDAQ | $USD |. Final infarct size, defined as the percentage of the left ventricular mass, was. Its lead product is Vascepa, a. The drug is also awaiting approval in China, where Amarin hopes to target the 50 million-plus cardiovascular disease patients with elevated risks. Earlier this month, Pfizer entered into a promotional agreement to. Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin/Pfizer can potentially promote Vascepa for COVID-19 Assuming Prepare-It 1 has positive results, can that information be used by Pfizer's Canadian sales reps when they visit physicians?. Amarin Corporation plc (AMRN) Stock Price Today, Quote & News | Seeking Alpha AMRN Amarin Corporation plc Stock Price & Overview $1. VASCEPA is a prescription medicine used: along with certain medicines (statins) to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with heart (cardiovascular) disease, or diabetes and 2 or more additional risk factors for heart disease.
Amarin Corp PLC (AMRN): Amarin has partnered with Eddingpharm ">Amarin Corp PLC (AMRN): Amarin has partnered with Eddingpharm.
Business: Amarin engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. However, there are several reasons why an acquisition of Amarin by Pfizer could pay off nicely. Pfizer (PFE) recently acquired an ontology company and could acquire Amarin (AMRN) next. Fresh from success with its omega-3 project Vascepa, Amarin is being touted as an acquisition target. 1% on Thursday, possibly on speculations that Pfizer PFE may bid to acquire the company. Pfizer's pipeline is as strong as it's been in a long time. Technical analysis trends AMARIN CORPORATION PLC Technical analysis Income Statement Evolution More Financials Consensus Consensus EPS Revisions More Estimates Revisions Managers and Directors More about the company More Results. Pfizer is said to be interested in Amarin, but the Danish group’s need for a growth injection is greater. For every giant drugmaker like Pfizer, Merck or Johnson & Johnson, whose products are in medicine cabinets around the world, there are countless startups and. Amarin is relentless in its pursuit of scientific breakthroughs that can lead to revolutionary solutions that create a healthier world. Amarin's product development program. Amarin is fully capitalized after their last $200m equity raise last November. Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O'Connor to Company's Board of Directors • GlobeNewswire Inc. Amarin's recent "Reduce-It" clinical trial results for its Vascepa drug were better than those of Pfizer's Lipitor, a drug that reached peak sales of $13. Importance of CV risk reduction by the care team in patients with high CV risk. Tardif reported research grants from Amarin, AstraZeneca, Ceapro, DalCor Pharmaceuticals, Esperion, Merck, Novartis, Pfizer, and RegenXBio; honoraria from AstraZeneca, DalCor Pharmaceuticals,. Pfizer (PFE) recently acquired an ontology company and could acquire Amarin (AMRN) next. (PFE), HLTRF, HLS:CA AMRN By: SA News Team 12 Comments HLS Therapeutics ( OTCPK:HLTRF ) has entered into a promotional services agreement with Pfizer ( NYSE. Amarin Corp - ADR (AMRN) Stock Price Today, News, Quotes, FAQs and Fundamentals Home Symbol AMRN AMRN Amarin Corp - ADR 31,245 $1. None of the NYSE or Nasdaq-listed biopharma stocks and medical device manufacturers hit fresh 52-week highs Nov. Pfizer CEO Bourla slams Medicare IRA measure as 'negotiation with a gun to your head' Fierce Pharma Monday, May 15, 2023 - 6:24pm tags: Pfizer, Albert Bourla, drug pricing, Pharma CEOs, Inflation Reduction Act After Hemgenix approvals, uniQure cashes out some of its royalty rights for $375M-plus Fierce Pharma Monday, May 15, 2023 - 6:23pm tags:. Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. This week Amarin’s drug will be presented at ESC Congress on August 29 with results that it. We are proud to add to the body of research that further.